Catalyst Wire Dossier Catalyst Wire Dossier

HER-2 pulsed dendritic cell vaccine

HER-2 pulsed dendritic cell vaccine · H. Lee Moffitt Cancer Center and Research Institute
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HER-2 pulsed dendritic cell vaccine, covering 2019-02-15 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy [Phase 1]

See pricing